-
Gludantan, or gludantane, is an
experimental antiparkinsonian agent of the
adamantane group that was
never marketed. It has also been
described as a "psychotropic"...
- agonism, and
dopaminergic modulation. The drug was
first described by 2000.
Gludantan Abaimov DA,
Kovalev GI (2011). "Sigma
receptors as a
pharmacological target...
-
similar effects include adapromine, amantadine, chlodantane,
gludantane (
gludantan), memantine, and rimantadine. The
reductive amination between Adamantanone...
-
bromantane (bromantan), carmantadine,
chlodantane (chlodantan), dopamantine,
gludantan (gludantane),
hemantane (hymantane),
idramantone (kemantane), memantine...
